- Home
- SF vs COO Comparison
SF vs COO Comparison
Compare SF & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SF | COO |
|---|---|---|
| Founded | 1890 | 1980 |
| Country | United States | United States |
| Employees | 9000 | N/A |
| Industry | Investment Bankers/Brokers/Service | Ophthalmic Goods |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 12.2B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | SF | COO |
|---|---|---|
| Price | $71.36 | $67.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 11 |
| Target Price | ★ $90.33 | $90.18 |
| AVG Volume (30 Days) | 1.2M | ★ 3.2M |
| Earning Date | 04-22-2026 | 05-28-2026 |
| Dividend Yield | ★ 1.76% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.27 |
| Revenue | N/A | ★ $2,532,800,000.00 |
| Revenue This Year | $14.58 | $6.66 |
| Revenue Next Year | $8.03 | $5.18 |
| P/E Ratio | ★ $20.53 | $250.70 |
| Revenue Growth | N/A | ★ 18.41 |
| 52 Week Low | $67.96 | $58.89 |
| 52 Week High | $134.74 | $89.83 |
Technical Indicators
Market Signals| Indicator | SF | COO |
|---|---|---|
| Relative Strength Index (RSI) | 42.99 | 64.52 |
| Support Level | $68.63 | $64.19 |
| Resistance Level | $74.07 | $70.01 |
| Average True Range (ATR) | 1.63 | 1.62 |
| MACD | 0.25 | 1.09 |
| Stochastic Oscillator | 55.96 | 88.24 |
Price Performance
Historical ComparisonAbout SF Stifel Financial Corporation
Stifel Financial is a diversified financial-services provider that generates revenue from wealth management, investment banking, and lending. The firm was founded in 1890 as a St. Louis-based full-service brokerage but has been transformed under CEO Ronald Kruszewski through a slew of acquisitions into a globally competitive wealth manager, investment bank, and retail and institutional brokerage. The firm generated $5.5 billion in revenue in 2025, with roughly two-thirds derived from wealth management and one-third derived from investment banking and trading.
About COO The Cooper Companies Inc.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.